What's new

Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 2, Status: Authorised

Apr 25, 2025 - 09:35
 0
Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Struggling lobbyists, panicked clients: D.C. comes to grips with Trump’s ...

Next Article

AI-powered Technical Drawing Analysis for Spare Part Digitization from 3YOURMIND

Related Posts

IRIS guide for applicants - How to create and submit sc...

Mar 12, 2025  0

DARWIN EU data partners onboarded in phases I and II

Feb 20, 2025  0

Orphan designation: ixodes ricinus contact phase inhibitor Treatment of non-traumatic spontaneous intracerebral haemorrhage, 25/03/2025 Positive

Orphan designation: ixodes ricinus contact phase inhibi...

Apr 4, 2025  0